E. Coli Testing Market By Type of Diagnostic Procedure 2021 | IndustryARC
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

E. Coli Testing Market
E. Coli Testing Market: By Type of Diagnostic Procedure (Monoclonal antibodies, Molecular diagnostics, Immunoassay, Differential light scattering & Others) & By End User/Application (Waste water treatment, Hospitals and diagnostic centers, Research laboratories & Others) & By Region-Forecast (2016-2021)
Report Code : HCR 0285
Published: 08 March, 2016   20% discount on this report

  • Report Description
  • Table of Contents
  • Customization Options
Escherichia coli (E. coli) are rod-shaped gram-negative bacteria that are commonly found in the environment, foods, and intestines of warm-blooded animals. Most of the E.coli strains are usually harmless to humans, but some strains identified to cause serious some medical complications like gastrointestinal tract infections, cholangitis, cholecystitis, bacteremia, neonatal meningitis and pneumonia, urinary tract infection (UTI), and mostly spread via contaminated food or water.

E.coli is also used to test the effectiveness of effluent disinfection in a wastewater treatment plant and check the fecal contamination in humans. Membrane filtration, multiple tube fermentation, enzyme substrate methods and presence/absence (P/A) tests are generally used to test water sample. P/A tests are mostly used due to their cost effectiveness and they do not require skilled laboratory personnel or sophisticated laboratory setup to perform the tests.

Globally with increase in E. coli infections, demand for quick and precision test kits is on the rise. Currently, there is larger market for enzyme immunoassay (EIA) kits. On the other hand, polymerase chain reactions (PCR) based tests are used to test specific drug resistant strain during epidemics.

This report provides information on E. coli testing market size for the year 2014-2016, and forecast of the same for year 2021. It also focuses on market drivers, challenges, restraints, market dynamics, growth indicators, competitive landscape, potential growth opportunities and other key aspects with respect to E. coli testing market.

E. Coli Testing Market

Emphasis on hygiene, increasing government support for E. coli testing, rising occurrence and high morbidity of E. coli infection worldwide is expected to drive the future market growth of E. coli testing. Technological advancement together with rising use of polymerase chain reaction (PCR) tests for environment water testing predicted to open up new growth possibility during the forecast period.

North America dominates the global E. coli testing market due to increased government funding on healthcare infrastructure and technological advancement in E. coli diagnostic procedures in the region. Government initiatives, rising population and increasing awareness about E. coli infections in Asia Pacific region is expected to witness robust growth in coming time.

In this report, global E. coli testing market segmented based on different diagnostic procedures, end-users and region as follows:
  • Based on emerging diagnostic procedures, the report covers immunoassays, monoclonal antibodies, molecular diagnostics, differential light scattering, diagnostic imaging, flow cytometry, gel micro droplets, and others
  • The E. coli testing market is segmented based on end-user - wastewater treatment organizations, hospitals, diagnostic laboratories, bottle water suppliers and others
  • This report further segmented based on regional potential markets for E. coli treatment. A detailed analysis by region – United States, Europe, Asia-Pacific (APAC) and Rest of the World (ROW), provided in this report
Sample Companies Profiled in this Report are:
  • Abbott Laboratories
  • Danaher Corporation
  • Bio-Rad Laboratories
  • Enzo Life Sciences, Inc.
  • Hologic
  • 10+
1. E. Coli Testing – Market Overview
2. Executive Summary
3. E. Coli Testing - Market Landscape 
   3.1. Market Share Analysis
   3.2. Comparative Analysis
      3.2.1. Product Benchmarking
      3.2.2. End User Profiling
      3.2.3. Top 5 Financials Analysis
4. E. Coli Testing - Market Forces
   4.1. Drivers
      4.1.1. Wider applications
   4.2. Restraints
   4.3. Opportunities
   4.4. Challenges
   4.5. Porter’s Five Force Analysis
      4.5.1. Bargaining Power of Suppliers
      4.5.2. Bargaining Power of Customers
      4.5.3. Threat of New Entrants
      4.5.4. Threat of Substitutes
      4.5.5. Degree of Competition
5. E. Coli Testing – Strategic Analysis
   5.1. Value Chain Analysis
   5.2. Pricing Analysis
   5.3. Opportunities Analysis
   5.4. Product/Market Life Cycle Analysis
   5.5. Suppliers and Distributors
6. E. Coli Testing Market
   6.1. By type of diagnostic procedure
      6.1.1. Monoclonal antibodies
      6.1.2. Molecular diagnostics
      6.1.3. Immunoassay
      6.1.4. Differential light scattering
      6.1.5. Others
   6.2. By Application
      6.2.1. Waste water treatment
      6.2.2. Hospitals and diagnostic centers
      6.2.3. Research laboratories
      6.2.4. Others
7. E. Coli Testing, By Geography
   7.1. Introduction
   7.2. America
      7.2.1. US 
      7.2.2. Canada
      7.2.3. Mexico
   7.3. Europe
      7.3.1. U.K
      7.3.2. France
      7.3.3. Germany
      7.3.4. Italy
      7.3.5. Spain
      7.3.6. Rest of Europe
   7.4. Asia Pacific
      7.4.1. China
      7.4.2. South Korea
      7.4.3. Japan
      7.4.4. India
      7.4.5. Rest of Asia Pacific
   7.5. RoW
8. Market Entropy
   8.1. Expansion
   8.2. Technological Developments
   8.3. Merger & Acquisitions, and Joint Ventures
   8.4. Supply - Contract
9. Company Profiles (Introduction, Financials, Key Insights, Key Strategy, Product Portfolio, SWOT Analysis)
   9.1. Abbott Laboratories
   9.2. Danaher Corporation
   9.3. Bio-Rad Laboratories
   9.4. Enzo Life Sciences, Inc.
   9.5. Hologic
   9.6. Meridian Bioscience, Inc.
   9.7. Dickinson and Company
   9.8. Olympus Corporation
   9.9. Novartis
   9.10. Johnson & Johnson
*More than 10 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
10. Appendix
   10.1. Abbreviations
   10.2. Sources
   10.3. Research Methodology
   10.4. Expert Insights
Please select Licence
Single User Licence:
US $4250
Corporate User Licence:
US $6250
Related Reports
0px;">Scroll